Prosecution Insights
Last updated: April 19, 2026
Application No. 17/932,159

PORTABLE ELECTROCARDIOGRAPHIC DEVICE, ELECTROCARDIOGRAM MEASUREMENT SYSTEM, AND NON-TRANSITORY RECORDING MEDIUM HAVING PROGRAM RECORDED THEREIN

Non-Final OA §101
Filed
Sep 14, 2022
Examiner
LEVICKY, WILLIAM J
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Omron Healthcare Co. Ltd.
OA Round
3 (Non-Final)
69%
Grant Probability
Favorable
3-4
OA Rounds
3y 5m
To Grant
98%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
397 granted / 572 resolved
-0.6% vs TC avg
Strong +29% interview lift
Without
With
+29.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
56 currently pending
Career history
628
Total Applications
across all art units

Statute-Specific Performance

§101
7.8%
-32.2% vs TC avg
§103
38.1%
-1.9% vs TC avg
§102
21.2%
-18.8% vs TC avg
§112
24.3%
-15.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 572 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submissions filed on 9/18/2025 and 10/16/2025 have been entered. Response to Arguments The previous 112(a), 112(b) and 101 (human organism) rejections have been withdrawn as a result of the amendments. Applicant's arguments filed 10/16/2025 have been fully considered but they are not persuasive. Applicant argues the analysis steps are performed in real-time and simultaneously that cannot be practically performed by a human mind, even aided by pen and paper, to yield a timely and medically relevant result. The examiner respectfully disagrees as humans routinely processed large amounts of data by hand before the advent of computers. As the court has explained, “the fact that the required calculations could be performed more efficiently via a computer does not materially alter the patent eligibility of the claimed subject matter.” Bancorp Servs., L.L.C. v. Sun Life Assur. Co. of Can. (U.S.), 687 F.3d 1266, 1278 (Fed. Cir. 2012). The Applicant argues the specific hardware configuration of the electrode unit, including a first electrode provided at a bottom of the portable electrocardiographic device, a second electrode and a third electrode provided at a top of the portable electrographic device is non-conventional. The examiner respectfully disagrees as 2020/0375568 in Figure 7 and Paragraph [0085] discloses a top electrode (front side) and a second electrode (back side) along with other electrodes on the front or back. Baxi (US Patent 9,204,814) discloses a handheld heart monitor 130 with a top electrode 134, a bottom electrode 138 and a third and fourth electrode 136 and 140 as shown in Figure 1 or the heart monitor as illustrated in Figure 3. Bojovic et al (US Patent 7,647,093), Figure 4 illustrates a mobile ECG device with an electrode at the bottom of the device, a second electrode, and a third electrode on the top. The Applicant argues the claimed invention constitutes a technological improvement in usability and accessibility to allow ordinary users to perform sophisticated ECG diagnostics that previously required expert interpretation. That the computations performed in real-tie and simultaneously, constitute a technical implementation of quantitative waveform computation and probabilistic decision making and cannot simply be substituted for a mental process and thus are patent eligible. The examiner respectfully disagrees as MPEP 2106.05(a) states it is important to note, the judicial exception alone cannot provide the improvement. Upon evaluation of the claim as a whole the electrode unit being claimed is not a technical improvement and the use of mobile portable electrocardiographic devices is well known routine and conventional. In addition, the use of such a device provides for a pre-solution activity of data gathering and does not rise to an improvement in technology. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim(s) recite(s) a mental process of filtering and analyzing ECG waveforms, detecting R-peaks and fiducial points, computing inter-beat intervals and waveform amplitudes and evaluating probabilistic conditions. This judicial exception is not integrated into a practical application because the electrode unit including a first electrode provided at a bottom of the portable electrocardiographic device, a second electrode and a third electrode provided at a top of the portable electrocardiographic device is a pre-solution activity for data gathering. The processor along with a storage unit is a generic computing structure to implement the abstract idea. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because ethe electrode unit including a first electrode provided at a bottom of the portable electrocardiographic device, a second electrode and a third electrode provided at a top of the portable electrocardiographic device is well-known routine and conventional as Pagoulatos et al (US Publication 2020/0375568) in Figure 7 and Paragraph [0085] discloses a top electrode (front side) and a second electrode (back side) along with other electrodes on the front or back. Baxi (US Patent 9,204,814) discloses a handheld heart monitor 130 with a top electrode 134, a bottom electrode 138 and a third and fourth electrode 136 and 140 as shown in Figure 1 or the heart monitor as illustrated in Figure 3. Bojovic et al (US Patent 7,647,093) in Figure 4 illustrates a mobile ECG device with an electrode at the bottom of the device, a second electrode, and a third electrode on the top. The use of generic computing structures such as control unit/processors and ROM or RAM that make up a storage unit is not sufficient to amount to significantly more than the judicial exception. The examiner notes that dependent claims 2 and 9 add a display unit which includes a liquid crystal display or LEDS and a setting unit comprising LEDS and buttons (claims 4, 11, 18, and 19) comprising LEDS and buttons are also considered part of a generic computing structure and do not add significantly more than the abstract idea itself. The remaining dependent claims further define the abstract idea and do not integrate the abstract idea into a practical application or recite significantly more. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to William J Levicky whose telephone number is (571)270-3983. The examiner can normally be reached Monday-Thursday 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /William J Levicky/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Sep 14, 2022
Application Filed
Feb 11, 2025
Non-Final Rejection — §101
May 14, 2025
Response Filed
Jun 13, 2025
Final Rejection — §101
Sep 17, 2025
Request for Continued Examination
Oct 02, 2025
Response after Non-Final Action
Oct 09, 2025
Applicant Interview (Telephonic)
Oct 10, 2025
Examiner Interview Summary
Mar 19, 2026
Non-Final Rejection — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589241
Dual Sensor Electrodes for Providing Enhanced Resuscitation Feedback
2y 5m to grant Granted Mar 31, 2026
Patent 12569690
CARDIAC CONTRACTILITY MODULATION FOR ATRIAL ARRHYTHMIA PATIENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569686
CHRONICALLY IMPLANTABLE SYSTEMS AND METHODS FOR AFFECTING CARDIAC CONTRACTILITY AND/OR RELAXATION
2y 5m to grant Granted Mar 10, 2026
Patent 12558557
DISCRIMINATION OF SUPRAVENTRICULAR TACHYCARDIAS IN COMBINED CCM-ICD DEVICE
2y 5m to grant Granted Feb 24, 2026
Patent 12544580
DETACHABLE LEADLESS PACEMAKER SYSTEM FOR CARDIAC CONDUCTION BUNDLE PACING
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
69%
Grant Probability
98%
With Interview (+29.1%)
3y 5m
Median Time to Grant
High
PTA Risk
Based on 572 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month